News|Articles|March 29, 2024

Pharma Pulse 3/29/24: Social Media Users Turn to Twitter for Guidance on Birth Control, Wider Availability of Oral Contraceptives & more

The latest news for pharma industry insiders.

Petros Pharmaceuticals Executive Discusses Wider Availability of Oral Contraceptive

In an interview with Pharm Exec Associate Editor Don Tracy, Fady Boctor, President, Chief Commercial Officer, Petros Pharmaceuticals talks about the recent availability of Opill as an over-the-counter contraceptive.

Social Media Users Turn to Twitter for Birth Control Guidance, Education

The authors note that these findings provide opportunities for health care professionals to utilize social media to reach patients and share accurate information.

Super Micro’s AI Boom Carries a Big Price Tag

Maker of Nvidia-based AI servers has a hot hand, but high-cost business model leaves stock looking overheated.

Urban Wellness Group Unveils Innovative Anti-Aging and Sleep Enhancement Technologies

Urban Wellness Group, a wellness provider, is proud to announce its official launch of new anti-aging and sleep enhancement treatments to southeast Portland.

Tony Klaich on LinkedIn:

#Pharmaceutical companies face an increasingly challenging and complex environment. In this Pharmaceutical Executive article, my Crowe colleagues Mindy Herman and Bo Qiu share how companies can build resiliency and better adapt to the changing market.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs


Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.
CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.